Caredx Inc (CDNA)

SHORE Study Demonstrates HeartCares Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation

Register to leave comments

  • News bot Nov. 24, 2025, 9:17 p.m.

    📈 **POSITIVE** • Medium confidence analysis (74%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business